https://www.firmenpresse.de/pressrelease18528/active-biotech-raises-sek-149-million-through-a-directed-share-issue.html
Active Biotech raises SEK 149 million through a directed share issue
The Board of Directors of Active Biotech has, pursuant to the authorizationgiven by the 2009 annual general meeting, resolved today to issue a tot ...
active biotechsekmilliondirectedshare
https://www.contractresearchmap.com/providers/active-biotech
Active Biotech Locations - Contract Research Map
active biotechcontract researchlocationsmap
https://www.financialnewsmedia.com/active-biotech-alert-fda-approves-16-new-cancer-treatments-as-global-cancer-rates-skyrocket/
Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket -...
Oct 4, 2024 - EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:ABBV),(NASDAQ:BGNE),(NASDAQ:HCM),(NASDAQ:ELVN) EQNX::TICKER_END
active biotechcancer treatmentsalertfdaapproves
https://www.bmpharmaceuticals.com/active-biotech-fda-grants-orphan-drug-designation-for-tasquinimod-for-the-treatment-of-multiple-myeloma/
Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for the treatment of multiple...
active biotechthe treatmentfdagrantsorphan
https://www.evotec.com/news/evotec-and-active-biotech-extend-and-expand-medicinal-chemistry-collaboration
Evotec and Active Biotech Extend and Expand Medicinal Chemistry Collaboration - Evotec
active biotechmedicinal chemistryevotecextendexpand
https://rapidus.se/company/active-biotech/
Active Biotech-arkiv - Rapidus
active biotecharkivrapidus
https://mfn.se/a/active-biotech/active-biotech-interim-report-q1-2026
MFN.se Active Biotech Active Biotech Interim Report Q1 2026
May 7, 2026 - EVENTS DURING THE FIRST QUARTER The US Patent Office (US PTO) granted a patent related to a pharmaceutical formulation of tasquinimod (January) Active Biotech...
active biotechinterim reportmfnse
https://www.pharmoutsourcing.com/1315-News/110533-Evotec-and-Active-Biotech-Extend-and-Expand-Medicinal-Chemistry-Collaboration/
Evotec and Active Biotech Extend and Expand Medicinal Chemistry Collaboration | Pharmaceutical...
Evotec and Active Biotech Extend and Expand Medicinal Chemistry Collaboration
active biotechmedicinal chemistryevotecextendexpand
https://www.wellington.com/en-ie/institutional/insights/why-now-for-active-biotech-investing
Why now for active biotech investing | Wellington Ireland Institutional
Oct 22, 2024 - From solid fundamentals to supportive macro conditions, learn why our biotech experts believe the industry may be ready to run.
why nowactive biotechinvestingwellingtonireland
https://www.dcatvci.org/top-industry-news/teva-active-biotech-advance-small-molecule-ms-drug-laquinimod/
Teva, Active Biotech Advance Small-Molecule MS Drug Laquinimod - DCAT Value Chain Insights
Sep 8, 2021 - Teva Pharmaceutical Industries Ltd. and Active Biotech, a biopharmaceutical company based in Lund, Sweden, have expanded their clinical development program for...
active biotechsmall moleculevalue chaintevaadvance
https://www.personalcareinsights.com/news/givaudan-active-beauty-launches-white-biotech-ingredient-neoporyl-to-shrink-enlarged-pores.html
Givaudan Active Beauty launches white biotech ingredient Neoporyl to shrink enlarged pores
Givaudan is debuting the active ingredient Neoporyl, which reportedly targets the root cause of large pores within one week.
active beautyenlarged poresgivaudanlauncheswhite
https://www.kennethresearch.com/report-details/global-active-pharmaceutical-ingredients-api-market/10325687
Global Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech,...
Global Active Pharmaceutical Ingredients (API) Market Insights includes market share, market research report, market trade, market prices, market geography...
pharmaceutical ingredientsapi marketglobalactivesynthesis